Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

[Molecular imaging-based early-phase and exploratory clinical research].

Watanabe Y.

Yakugaku Zasshi. 2013;133(2):187-95. Review. Japanese.

2.

[Application of pre-clinical PET imaging for drug development].

Tsukada H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Nov;31(5-6):231-7. Review. Japanese.

PMID:
22256612
3.

[Regulatory authorities expect innovative drug delivery systems (DDS)].

Mori K.

Yakugaku Zasshi. 2013;133(1):73-80. Review. Japanese.

5.

[Molecular imaging for drug development].

Watanabe Y.

Brain Nerve. 2007 Mar;59(3):209-14. Review. Japanese.

PMID:
17370646
6.

Target-specific delivery of peptide-based probes for PET imaging.

Chen K, Conti PS.

Adv Drug Deliv Rev. 2010 Aug 30;62(11):1005-22. doi: 10.1016/j.addr.2010.09.004. Epub 2010 Sep 17. Review.

PMID:
20851156
7.

[Consideration on molecular imaging technology as a tool for drug research and development].

Yajima K, Nishimura S.

Yakugaku Zasshi. 2009 Mar;129(3):297-304. Review. Japanese.

8.

A rational regulatory approach for positron emission tomography imaging probes: from "first in man" to NDA approval and reimbursement.

Barrio JR, Marcus CS, Hung JC, Keppler JS.

Mol Imaging Biol. 2004 Nov-Dec;6(6):361-7.

PMID:
15564146
9.

[Molecular imaging for drug development].

Watanabe Y.

Nihon Rinsho. 2007 Feb;65(2):357-62. Japanese.

PMID:
17302284
10.

Matching Chelators to Radiometals for Positron Emission Tomography Imaging- Guided Targeted Drug Delivery.

Deng H, Wang H, Li Z.

Curr Drug Targets. 2015;16(6):610-24. Review.

PMID:
26148988
11.

Translational PET imaging research.

Hargreaves RJ, Rabiner EA.

Neurobiol Dis. 2014 Jan;61:32-8. doi: 10.1016/j.nbd.2013.08.017. Epub 2013 Sep 17. Review.

PMID:
24055214
12.

Radiopharmaceuticals: molecular imaging using positron emission tomography.

Antoni G, Långström B.

Handb Exp Pharmacol. 2008;(185 Pt 1):177-201. doi: 10.1007/978-3-540-72718-7_9. Review.

PMID:
18626804
13.
14.

Developing new molecular imaging probes for PET.

Serdons K, Verbruggen A, Bormans GM.

Methods. 2009 Jun;48(2):104-11. doi: 10.1016/j.ymeth.2009.03.010. Epub 2009 Mar 24. Review.

PMID:
19318126
15.

Positron emission tomography molecular imaging for drug development.

Matthews PM, Rabiner EA, Passchier J, Gunn RN.

Br J Clin Pharmacol. 2012 Feb;73(2):175-86. doi: 10.1111/j.1365-2125.2011.04085.x. Review.

16.

Positron Emission Tomography: applications in drug discovery and drug development.

Wang J, Maurer L.

Curr Top Med Chem. 2005;5(11):1053-75. Review.

PMID:
16181131
17.

Iodine-124 as a label for pharmacological PET imaging.

Belov VV, Bonab AA, Fischman AJ, Heartlein M, Calias P, Papisov MI.

Mol Pharm. 2011 Jun 6;8(3):736-47. doi: 10.1021/mp100358f. Epub 2011 Apr 6.

PMID:
21361362
18.

Small-animal PET: a promising, non-invasive tool in pre-clinical research.

Schnöckel U, Hermann S, Stegger L, Law M, Kuhlmann M, Schober O, Schäfers K, Schäfers M.

Eur J Pharm Biopharm. 2010 Jan;74(1):50-4. doi: 10.1016/j.ejpb.2009.05.012. Epub 2009 May 29.

PMID:
19482080
19.

Microwave accelerated labeling methods in the synthesis of radioligands for positron emission tomography imaging.

Kallmerten AE, Alexander A, Wager KM, Jones GB.

Curr Radiopharm. 2011 Oct;4(4):343-54. Review.

PMID:
22202157
20.

[In vivo imaging of liposomal small interfering RNA (siRNA) trafficking by positron emission tomography].

Ando H, Yonenaga N, Asai T, Hatanaka K, Koide H, Tsuzuku T, Harada N, Tsukada H, Oku N.

Yakugaku Zasshi. 2012;132(12):1373-81. Review. Japanese.

Supplemental Content

Support Center